2 ARV access EMRO Survey

Information about 2 ARV access EMRO Survey

Published on May 8, 2008

Author: Siro

Source: authorstream.com

Content

Slide1:  Access to ARVs in EMR: Findings of the Survey EDB / ASD 5-7 April, 2005, Cairo Inter-country Meeting on Antiretroviral Drugs Pricing, Procurement and Supply Management About the survey :  About the survey A quick attempt to get information about the ARVs supply situation in the EMR countries. A questionnaire was sent to pharmaceutical authorities in all the countries. 12 out of 22 countries responded. The data was analyzed and being presented in this presentation. Responses received from :  Responses received from Afghanistan Bahrain Djibouti Egypt Iran Iraq Jordan Kuwait Lebanon Libya Morocco Oman Pakistan Palestine Qatar Saudi Arabia Somalia Sudan Syria Tunisia UAE Yemen What we asked for ? 1 :  What we asked for ? 1 Is there a National Medicines Policy approved by the government? Is there a national EDL? If yes, does the NEDL include ARVs? Does the public medicine procurement and supply agency procure and supply ARVs? - if yes, what is the procurement policy? - If not, then please specify the ARV procurement and supply system in your country? On which treatment guidelines is the procurement list of ARVs based? - National guidelines - WHO guidelines - Others (please specify)? Slide5:  6. Are ARVs locally produced? - if yes, list the ARVs which are locally procured? - If no, then please specify the sources of ARV procurement and provide a breakdown of ARVs procured per year (estimates if exact figures are not available)? - Brand name ARVs: …% - Generic ARVs …% Please list the 10 ARVs that are most commonly procured and used in your country (in order of priority)? Briefly explain what obstacles are experienced in procurement and supply of ARVs Does the public medicines procurement and supply agency also procure and supply diagnostic kits? What we asked for ? 2 Slide6:  Are there regulations which allow fast track registration of generics and/or medicines included in national EDL? Is your country a WTO member? If yes, does the law in your country allow to utilize TRIPS provisions? In case your country is not a WTO member: does your current patent legislation have safeguards which allow to use generics? What we asked for ? 3 Slide7:  14. Have you ever used list of WHO prequalified ARVs for registration or procurement purposes? What we asked for ? 4 Is there a National Medicines Policy approved by the government ?:  Is there a National Medicines Policy approved by the government ? 11 out of 12 countries have NMP? Afghanistan Egypt Iran Jordan Lebanon Oman Palestine Sudan Syria Tunisia UAE Yemen 2. Is there a national EDL?:  2. Is there a national EDL? 11 out of 12 countries have NEDL? Afghanistan Egypt Iran Jordan Lebanon Oman Palestine Sudan Syria Tunisia UAE Yemen 3. Does the NEDL include ARVs?:  3. Does the NEDL include ARVs? 11 out of 12 countries include ARVs in their NEDL? Afghanistan Egypt Iran Jordan Lebanon Oman Palestine Sudan Syria Tunisia UAE Yemen 4.a Does the public medicine procurement and supply agency procure and supply ARVs? :  4.a Does the public medicine procurement and supply agency procure and supply ARVs? In 10 out of 12 countries public sector procure and supply ARVs Afghanistan Egypt Iran Jordan Lebanon Oman Palestine Sudan Syria Tunisia UAE Yemen 4.b - If yes, what is the procurement policy?:  4.b - If yes, what is the procurement policy? 5. On which treatment guidelines is the procurement list of ARVs based? :  5. On which treatment guidelines is the procurement list of ARVs based? 5. Are ARVs locally produced?:  5. Are ARVs locally produced? 6. List of ARVs produced locally:  6. List of ARVs produced locally 6. Availability of ARVs with brand names and generic names in EMR countries:  6. Availability of ARVs with brand names and generic names in EMR countries 7. 10 Most commonly used ARVs in reporting EMR countries:  7. 10 Most commonly used ARVs in reporting EMR countries 8. Obstacles are experienced in procurement and supply of ARVs:  8. Obstacles are experienced in procurement and supply of ARVs 9. Public Procurement & Supply of diagnostic kits?:  9. Public Procurement & Supply of diagnostic kits? All the countries which procure ARVs through medicine supply agencies also procure diagnostic kits. Afghanistan Egypt Iran Jordan Lebanon Oman Palestine Sudan Syria Tunisia UAE Yemen 10. Are there regulations which allow fast track registration of essential drugs?:  10. Are there regulations which allow fast track registration of essential drugs? 11. WTO membership?:  11. WTO membership? 12. If yes, does the law in your country allow to utilize TRIPS flexibilities / safeguards?:  12. If yes, does the law in your country allow to utilize TRIPS flexibilities / safeguards? 13. In case your country is not a WTO member: does your current patent legislation have safeguards which allow to use generics?:  13. In case your country is not a WTO member: does your current patent legislation have safeguards which allow to use generics? 14.Have you ever used list of WHO pre-qualified ARVs for registration or procurement purposes?:  14.Have you ever used list of WHO pre-qualified ARVs for registration or procurement purposes? 6 out of 12 countries have used it Afghanistan Egypt Iran Jordan Lebanon Oman Palestine Sudan Syria Tunisia UAE Yemen Conclusions :  Conclusions Responses received from 12 out of 22 countries. 10 out of 12 countries have NMPs. 11 out of 12 countries have NEDLs. Big majority have included ARVs in their NEDLs. Almost all countries procure ARVs through public sector supply system. All the countries either have National treatment guidelines or they use WHO guidelines. Only Iran and Egypt are manufacturing ARVs in the region. There is a mixed situation about the use of branded and generic ARVs in the reporting countries. High prices and delay in supply are the most common obstacles mentioned in access to ARVs. Conclusions :  Conclusions All the countries also procure diagnostic kits through the same systems. Majority of the countries (9/12) have regulations for fast-track registration of essential drugs. 5 countries are WTO members and 7 are not. WTO members have important flexibilities and safeguards in their patent laws. Non-WTO members also have enabling patent laws for generic use. Half of the countries have used pre-qualification information in their procurement work.

Related presentations


Other presentations created by Siro

industry shampoo
13. 01. 2008
0 views

industry shampoo

communication skills
28. 01. 2008
0 views

communication skills

OzoneDepletion
20. 02. 2008
0 views

OzoneDepletion

Wine Tour 07
06. 02. 2008
0 views

Wine Tour 07

Samsung Electronics Master
08. 04. 2008
0 views

Samsung Electronics Master

Leap for London assembly Primary
02. 05. 2008
0 views

Leap for London assembly Primary

4Unit 1
24. 04. 2008
0 views

4Unit 1

LateralThinking
16. 04. 2008
0 views

LateralThinking

poole
21. 03. 2008
0 views

poole

SOLUTIONS 2007 Conference Guide
19. 03. 2008
0 views

SOLUTIONS 2007 Conference Guide

RutgersTB2
15. 03. 2008
0 views

RutgersTB2

JHP a FRBR ENG
11. 03. 2008
0 views

JHP a FRBR ENG

delta777
09. 01. 2008
0 views

delta777

bentivegna thesis04
10. 01. 2008
0 views

bentivegna thesis04

DetroitScience Center
10. 01. 2008
0 views

DetroitScience Center

michigan0319a
13. 01. 2008
0 views

michigan0319a

asso 12b25
14. 01. 2008
0 views

asso 12b25

Intro overview
16. 01. 2008
0 views

Intro overview

d000511
18. 01. 2008
0 views

d000511

Solar Water Pumps in Kansas
23. 01. 2008
0 views

Solar Water Pumps in Kansas

trt8fm
17. 01. 2008
0 views

trt8fm

Psalms Class 1
04. 02. 2008
0 views

Psalms Class 1

Deuteronomy6Sermon
04. 02. 2008
0 views

Deuteronomy6Sermon

Cellular Phones
04. 02. 2008
0 views

Cellular Phones

AIG PTF March 03
04. 02. 2008
0 views

AIG PTF March 03

TSIL Shareholders 160606
11. 02. 2008
0 views

TSIL Shareholders 160606

102
21. 01. 2008
0 views

102

20050717 worship
29. 01. 2008
0 views

20050717 worship

jiyeong0414
10. 01. 2008
0 views

jiyeong0414

MEMS
13. 02. 2008
0 views

MEMS

01 rlsss
25. 02. 2008
0 views

01 rlsss

MD SuDeChallenges TTBe
09. 01. 2008
0 views

MD SuDeChallenges TTBe

Laura Gitlin
16. 01. 2008
0 views

Laura Gitlin

DBillington
11. 01. 2008
0 views

DBillington

4 Nakatani
24. 01. 2008
0 views

4 Nakatani

GRD MatE
22. 01. 2008
0 views

GRD MatE

e0
05. 02. 2008
0 views

e0

Presentation23
11. 01. 2008
0 views

Presentation23

FAUVE PORTRAITS
26. 02. 2008
0 views

FAUVE PORTRAITS